Get more information on LUCENTIS: 1-866-LUCENTIS
(1-866-582-3684)
Monday-Friday 8AM-9PM (EST)
You'll receive helpful tips & tools, a free information kit, and much more.
Call 1-866-LUCENTIS to learn about resources that can help you in getting LUCENTIS.
What is wet AMD?
Wet AMD is the most serious form of AMD. And, it can progress very quickly. Although only 10% of people (1 out of 10) with dry AMD will get wet AMD, it is a major cause of vision loss in adults. About 200,000 people are diagnosed each year.
Wet AMD occurs with the abnormal growth of blood vessels in the back of the eye. These blood vessels grow specifically under your retina. As the blood vessels grow, they can leak blood and fluid, which can cause scarring on your retina and substantial damage to the macula. This leakage may result in the loss of your central vision.
The earliest symptom of AMD is vision change. If you notice that straight lines appear wavy, or that door frames don't seem straight, you should get an eye exam as soon as this occurs. It may be an early sign of wet AMD. Today, retina specialists can prevent vision loss from getting worse or even help you get some of your vision back. But early diagnosis is critical. If you think you have symptoms of wet AMD, see your eye doctor immediately.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).
Important LUCENTIS Safety Information
Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.
Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.
Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.
Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.
The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.
